0001517022-23-000004.txt : 20230525 0001517022-23-000004.hdr.sgml : 20230525 20230525164409 ACCESSION NUMBER: 0001517022-23-000004 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230525 DATE AS OF CHANGE: 20230525 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 23961523 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Dahan Michel CENTRAL INDEX KEY: 0001669737 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AKEBIA THERAPEUTICS, INC. STREET 2: 245 FIRST STREET, SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 144 1 primary_doc.xml 144 0001669737 XXXXXXXX LIVE 0001517022 Akebia Therapeutics, Inc. 001-36352 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098 Dahan Michel Officer Common Stock Morgan Stanley Smith Barney LLC

1 New York Plaza, 38th Floor New Yord NY 10004

95478 116760.00 185928121 05/25/2023 NASDAQ Common 05/25/2023 Restricted Stock Akebia Therapeutics, Inc N 95478 05/25/2023 N/A N Michel Dahan

c/o 245 First Street Cambridge MA 02142

Restricted Stock 03/01/2023 20412 17912.00 Michel Dahan

c/o 245 First Street Cambridge MA 02142

Restricted Stock 02/27/2023 10090 8205.00 05/25/2023 Carolyn Rucci